- CVR Medical (CVM) has closed the first tranche of a non-brokered private placement for gross proceeds of $115,000
- The first tranche consisted of 3,850,000 units priced at $0.03 per unit
- The offering, a necessary step in relaunching operations under new leadership, may be closed in additional tranches
- CVR Medical is a healthcare company that operates in the medical device industry focused on the commercialization of its proprietary CSS, a device designed to detect and measure carotid arterial stenosis
- CVR Medical Corp. (CVM) is down 14.29 per cent on the day, trading at C$0.03 per share at 4 pm EST
CVR Medical (CVM) has closed the first tranche of a non-brokered private placement for gross proceeds of $115,000.
The first tranche consisted of 3,850,000 units priced at $0.03 per unit. Each unit consists of one common share and one transferable common share purchase warrant. Warrants are exercisable to acquire an additional common share for $0.12 per share.
The proceeds from the offering will be used to cover the costs of the Annual General Meeting and filings fees.
Completion of the offering is a necessary step in relaunching operations under new leadership, with the ultimate goal of commercializing the Carotid Stenotic Scan device.
The common shares and warrants will be subject to a hold period expiring April 24, 2022.
The offering may be closed in additional tranches.
CVR Medical Corp. is a healthcare company that operates in the medical device industry focused on the commercialization of its proprietary Carotid Stenotic Scan device (CSS). The CSS is a patented device designed to detect and measure carotid arterial stenosis.
CVR Medical Corp. (CVM) is down 14.29 per cent on the day, trading at C$0.03 per share at 4 pm EST.
